Browse Category

Financial Analysis News 15 October 2025 - 16 October 2025

Shocking CFO Departure Sends BDX Stock Tumbling — But Growth Remains Strong

Shocking CFO Departure Sends BDX Stock Tumbling — But Growth Remains Strong

Leadership Change and Growth: BD’s CFO Chris DelOrefice surprised the market by resigning in mid-October prnewswire.com. According to the official release, DelOrefice is pursuing an outside opportunity, and Roque will cover the CFO role through the transition. Polen emphasized DelOrefice’s
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Novo Nordisk Licensing Deal Sparks Rally On Oct. 15, Novo Nordisk (NYSE: NVO) and Omeros announced a landmark deal licensing zaltenibart (OMS906), Omeros’s experimental MASP-3 inhibitor for rare blood/kidney diseases investor.omeros.com. Under the agreement, Novo pays $340M upfront and can
1 84 85 86 87 88 94
Go toTop